Wendy’s rejects $1.4 billion takeover proposal from Nelson Peltz’s Trian

by | Nov 14, 2026 | Stock Market

Wendy's rejects $1.4 billion takeover proposal from Nelson Peltz’s Trian

Wendy’s declined a takeover bid valued at $1.4 billion from an investor consortium led by Nelson Peltz’s Trian Fund Management. The group, which also included BlueFive Capital, Sixth Street Partners, and Flynn Group, submitted an offer of $7.35 per share in cash in late October to take the fast-food chain private.

Wendy’s board, through an independent committee of directors formed in February to evaluate any potential Trian proposal, determined the offer substantially undervalues the company and does not account for prospective value from the burger chain’s ongoing operational turnaround efforts. Board Chair Art Winkleblack expressed confidence in CEO Bob Wright’s leadership and industry experience. Trian declined to comment on the rejection.

In response to the bid, Wendy’s implemented a shareholder rights plan, commonly known as a poison pill, effective as of the previous day, with a one-year duration. The company noted that the investor group rejected its offer for a standstill agreement that would have restricted additional share purchases, contributing to the decision to deploy the defensive measure. The latest chapter in this saga extends a decades-long relationship between Peltz and the company, beginning with an activist campaign more than twenty years ago. Peltz’s firm previously owned Wendy’s following a $2.3 billion acquisition in 2008, which also included Arby’s. Current board members include Trian executive Peter May and Bradley Peltz, the activist investor’s son.

Wendy’s reported third-quarter earnings and revenue that exceeded Wall Street estimates, though same-store sales declined for the seventh consecutive quarter. Share prices declined less than 1% in morning trading following the rejection announcement. The stock has fallen approximately 60% in value over the preceding three years, though the takeover offer had initially boosted the share price. Similar defensive tactics have emerged elsewhere in the restaurant sector, with Applebee’s parent company Dine Brands also recently adopting a poison pill strategy against acquisition attempts from Arkhouse Management and Cobblers Cove Capital.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI